Company
Sydney, NSW
Every investor coverage indicates participated in a round Portland Orthopaedics Limited raised.
The transaction that ended Portland Orthopaedics Limited's run as a startup, per published coverage. It closes the funding history too, where it is the ladder's last rung.
| Bought by | Kind | Announced | Price | Sources |
|---|---|---|---|---|
| - | IPO | 21 Dec 2005 | $4m | GBS Ventures (21 Dec 2005), GBS Ventures (12 Dec 2005) |
Companies Portland Orthopaedics Limited acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Portland Orthopaedics Limited. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Portland Orthopaedics wins US FDA approval for its Beacon Primary Knee, licensed from Signal Medical, and uses an AusIndustry grant to develop a revision knee product.
A 2005 GBS Ventures news post records Portland Orthopaedics' stock market debut at a 12% premium, with detail left to an attached document rather than given on the page itself.
Also GBS Ventures
A 2005 notice that Portland Orthopaedics, a Sydney hip and knee implant maker, planned a $5 million IPO, with a December ASX listing expected and Axis Financial Group brokering the offer.